Neuraxis, Inc. 宣布发放第三季度股票股息
Neuraxis, INC (0001933567) (Filer)
Neuraxis, Inc. 宣布以普通股形式发放第三季度股票股息。每股优先股可获约 2.38 美元的股息,预计发行约 81,339 股普通股。股息将于 10 月 30 日支付给 10 月 26 日收盘时的优先股持有人。
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): October 14, 2026
Neuraxis, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 001-41775 | 45-5079684 | ||
(State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
11611 N. Meridian St, Suite 330
Carmel, IN 46032
(Address of principal executive offices)
Registrant’s telephone number, including area code: (812) 689-0791
N/A
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading Symbol(s) | Name of each exchange on which registered | ||
| Common Stock, $0.001 par value | NRXS | NYSE American |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 8.01 Other Events
On October 14, 2026, the Board of Directors of Neuraxis, Inc. (the “Company”) authorized and the Company declared a stock dividend on the Company’s Series B Preferred Stock, par value $0.001 per share (the “Series B Preferred Stock”) for the third quarter of 2026 (the “Third Quarter Dividend”). The Third Quarter Dividend will be paid in the form of shares of the Company’s common stock, par value $0.001 per share (the “Common Stock”). The number of shares of Common Stock to be received by each holder will be determined based on the accrued and unpaid dividends on such holder’s Series B Preferred Stock from July 1, 2026 through the record date, divided by $2.38. A total of approximately 81,339 shares of Common Stock are expected to be issued in connection with the Third Quarter Dividend. No fractional shares will be issued in connection with the Third Quarter Dividend. In lieu of any fractional shares, holders of Series B Preferred Stock who would otherwise be entitled to receive a fractional share of Common Stock will receive cash (without interest or deduction) in an amount equal to the product obtained by multiplying (a) $2.38 by (b) the fraction of one share of Series B Preferred Stock owned by such holder. The Third Quarter Dividend will be payable on October 30, 2026, to holders of record of the Company’s Series B Preferred Stock as of the close of business on October 26, 2026.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Date: October 14, 2026 | NEURAXIS, INC. | |
| By: | /s/ Brian Carrico | |
| Name: | Brian Carrico | |
| Title: | President and Chief Executive Officer | |
来源:SEC EDGAR · 本站存档